Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Professor utilizes $300,000 N.Y. grant to study adult neural stem cells

Professor utilizes $300,000 N.Y. grant to study adult neural stem cells

Caspase inhibition can prevent brain inflammation in neurological diseases

Caspase inhibition can prevent brain inflammation in neurological diseases

St. Joseph's Hospital launches new neuromodulation center in Barrow

St. Joseph's Hospital launches new neuromodulation center in Barrow

California leaders completes much-anticipated State Plan for Alzheimer's disease

California leaders completes much-anticipated State Plan for Alzheimer's disease

Vascular disorder of the brain most frequently misdiagnosed as multiple sclerosis

Vascular disorder of the brain most frequently misdiagnosed as multiple sclerosis

KineMed extends collaboration with BMY to identify and characterize Alzheimer's biomarkers

KineMed extends collaboration with BMY to identify and characterize Alzheimer's biomarkers

NeuroDerm commences ND0611 Phase I/II trial to treat Parkinson's disease

NeuroDerm commences ND0611 Phase I/II trial to treat Parkinson's disease

Economic benefits of enabling people to age at home

Economic benefits of enabling people to age at home

USPTO grants new patent to Intellect's Alzheimer's vaccine

USPTO grants new patent to Intellect's Alzheimer's vaccine

Psychosocially hazardous neighborhood may influence cognitive function in older age

Psychosocially hazardous neighborhood may influence cognitive function in older age

Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists

Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists

Stroke survivors with atrial fibrillation may be at greater risk of developing Dementia

Stroke survivors with atrial fibrillation may be at greater risk of developing Dementia

Vegetables can help reverse or prevent cancers

Vegetables can help reverse or prevent cancers

SMER28 can reduce beta-amyloid accumulation in patients with Alzheimer's disease

SMER28 can reduce beta-amyloid accumulation in patients with Alzheimer's disease

Study: Moderate drinking can reduce risk of dementia even among older adults

Study: Moderate drinking can reduce risk of dementia even among older adults

Researchers find new strategy for long-term care of seniors

Researchers find new strategy for long-term care of seniors

North Shore-LIJ launches new prenatal quality initiative

North Shore-LIJ launches new prenatal quality initiative

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

Prevalence of bipolar disorder

Prevalence of bipolar disorder

Prestige Assisted Living at Sierra Vista to host educational speaker series that explores memory care issues

Prestige Assisted Living at Sierra Vista to host educational speaker series that explores memory care issues

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.